Migraine Briefs

Plasma glucose increases during spontaneous migraine attacks


 

Key clinical point : Plasma glucose level increases during spontaneous migraine attacks, and the increase is independent of the presence of aura symptoms and pain intensity.

Main finding : Plasma glucose levels were higher in the ictal phase than in the interictal phase of migraine (mean, 98.83 vs. 88.63 mg/dL; P = .0014) after adjusting for diurnal variation. The attack-related elevation in plasma glucose level was not influenced by pain intensity or the presence of aura symptoms.

Study details : In this study, plasma glucose levels were measured during and outside of spontaneous attacks of migraine in 31 patients (13 with aura and 18 without aura).

Disclosures: The study was funded by the Lundbeck Foundation, the Novo Nordisk Foundation, the University of Copenhagen, the Research Foundation of the Capital Region of Denmark, and the Danish Council for Independent Research-Medical Sciences. Faisal Mohammad Amin and Anders Hougaard reported receiving personal fees and/or honoraria from multiple pharmaceutical companies. Messoud Ashina reported consultancy/advisory for multiple pharmaceutical companies. Other authors declared no disclosures.

Citation: Zhang DG et al. Headache. 2020 Feb 7. doi: 10.1111/head.13760 .

Recommended Reading

Migraine Linked to Adverse Pregnancy Outcomes
Migraine ICYMI
Low Sleep Efficiency Linked to Higher Risk of Migraine
Migraine ICYMI
Migraine: Vitamin D Might Improve Headache Characteristics and Reduce Inflammation
Migraine ICYMI
Migraine: What Are the Risk Factors for Flunarizine-Induced Parkinsonism?
Migraine ICYMI
Episodic Migraines Not Linked to Subsequent Sleep Disturbances
Migraine ICYMI
American Headache Society updates guideline on neuroimaging for migraine
Migraine ICYMI
Researchers develop score to predict risk of stroke among migraineurs with aura
Migraine ICYMI
Do urgent care centers use optimal medications for acute migraine?
Migraine ICYMI
Patients with acute migraine can benefit from rimegepant
Migraine ICYMI
Quarterly OnabotulinumtoxinA provides long-lasting prevention of chronic migraine
Migraine ICYMI